Abstract
This study was designed to determine the role of mucosal generation of prostaglandins (PGs) in the ability of mild irritants (20% ethanol or 5% NaCl) to protect against the formation of mucosal lesions caused by necrotizing agents (100% ethanol or 25% NaCl) or acidified aspirin (ASA). Mild irritants protected against damage from necrotizing agents but not from ASA. This protection was accompanied by increased mucosal generation of PGE2 and PGI2-like substances. Exogenous PGE2 and PGI2 applied topically to the gastric mucosa in a nonantisecretory dose greatly inhibited the formation of lesions induced by either necrotizing agents or ASA. Pretreatment with indomethacin, which suppressed the generation of mucosal PGs augmented formation of lesions by necrotizing agents and partly counteracted the protective effect of mild irritants. We conclude that mild irritants, and exogenous PGs inhibit the formation of gastric lesions by necrotizing agents, at least in part, by mucosal generation of PGs.
Similar content being viewed by others
References
Robert A: Cytoprotection and prostaglandins. Gastroenterology 77:761–767, 1979
Miller TA, Jacobson ED: Gastrointestinal cytoprotection by prostaglandins. Gut 20:75–87, 1979
Robert A, Lancaster C, Hanchar AJ, Nezamis JE: Mild irritants prevent gastric necrosis through prostaglandin formation: Histological study. Gastroenterology 74:1086, 1978
Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature 231:232–235, 1971
Robert A, Nezamis JE, Lancaster C, Hanchar AJ: Endogenous formation of cytoprotective prostaglandins prevents gastric necrosis produced by ethanol and thermal injury. Physiologist 20:79, 1977
Kauffman GL, Grossman MI: Prostaglandin and cimetidine inhibit the formation of ulcers produced by parenteral salicylate. Gastroenterology 75:1099–1102, 1978
Konturek SJ, Piastucki I, Brzozowski T, Radecki T, Dembinska-Kiec A, Zmuda A, Gryglewski RJ: Role of prostaglandins in the formation of aspirin-induced gastric ulcers. Gastroenterology 80:4–9, 1981
Whittle BJR: Potential endogenous inhibitor of prostaglandin synthetase is plasma failure to inhibit cyclooxygenase in platelets and the gastric mucosa. J Pharmacol Pharm 30:467–468, 1978
Vane JR: The use of isolated organs for detecting active substances in the circulating blood. Br J Pharmacol Chemother 23:360–373, 1964
Gryglewski RJ, Bunting S, Moncada S, Flower RJ, Vane JR: Arterial walls are protected against deposition of platelets thrombi by a substance (Prostaglandin x) which prevents platelet aggregation. Prostaglandins 12:685–689, 1976
Lane A, Ivy AC: Response of the chronic gastric fistula rat to histamine. Am J Physiol 190:221–228, 1957
Konturek SJ, Demitrescu T, Radecki T, Pucher A: Effect of glucagon on gastric and pancreatic secretion and peptic ulcer formation in cats. Am J Dig Dis 19:557–560, 1974
Robert A, Nezamis JE, Lancaster C, Hanchar AJ: Cytoprotection by prostaglandins in rats: Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl and thermal injury. Gastroenterology 77:433–443, 1979
Smith JB, Willis AL: Aspirin selectively inhibits prostaglandin production in human platelets. Nature 231:235–237, 1971
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Konturek, S.J., Brzozowski, T., Piastucki, I. et al. Role of locally generated prostaglandins in adaptive gastric cytoprotection. Digest Dis Sci 27, 967–971 (1982). https://doi.org/10.1007/BF01391740
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01391740